Core Laboratories N.V.

NYSE: CLB · Real-Time Price · USD
10.63
0.03 (0.28%)
At close: Aug 15, 2025, 2:10 PM

Core Laboratories Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
29.95M 28.32M 31.47M 26.2M 23.71M 37.52M 36.74M 41.23M 39.63M 23.94M 19.66M 15.76M 9.11M 10.17M 20.22M 31.52M 33.51M 19.62M
Depreciation & Amortization
14.73M 14.83M 14.95M 15.16M 15.42M 15.58M 15.78M 15.98M 16.23M 16.65M 17.16M 17.49M 17.81M 18.2M 18.52M 18.95M 19.62M 20.3M
Stock-Based Compensation
2.34M 1.67M 2.33M 4.35M 8.32M 9.81M 13.97M 12.71M 12.88M 10.51M 7.76M 9.9M 16.23M 20.91M 19.09M 7.79M 2.08M 1.27M
Other Working Capital
392.58K 7.03M 1.6M 13.76M 4.63M -2.73M -298.42K -15M -7.98M -5.19M -9.6M 3.79M 223.99K 3M 9.43M -3.78M -1.2M -5.35M
Other Non-Cash Items
-744.7K 752.41K -917.59K -2.49M -3.5M 6.02M 3.97M 7.05M 6.9M -8.12M -10.49M -11.67M -9.49M -6.59M -15.76M -35.5M -34.53M -19.39M
Deferred Income Tax
-1.72M -3.97M 674K 4.05M 3.17M -5.19M -7.08M -8.79M -11.12M -329K 433K 1.15M 3.81M 3.01M 6.01M 3.86M -1.93M -138K
Change in Working Capital
9.74M 15.92M 7.88M 7.93M -5.23M -18.67M -27.02M -38.03M -28.28M -26.16M -9.56M -13.72M -12.47M -11.82M -11.5M -106K 16.49M 31.11M
Operating Cash Flow
54.3M 57.52M 56.39M 55.2M 41.89M 33.52M 24.83M 18.61M 24.67M 16.5M 24.96M 18.9M 25M 33.88M 36.58M 26.51M 35.25M 52.76M
Capital Expenditures
-10.69M -13.53M -13M -11.25M -12M -11.36M -10.52M -9.91M -9.14M -10.13M -10.22M -12.95M -13.38M -13.06M -13.54M -12.09M -11.13M -11.31M
Cash Acquisitions
n/a 204.8K 797.8K 857.42K 924.71K 905.44K 482.44K 2.49M 1.91M 2.16M 2.07M 360K 583K 669.37K 588.37K 228.37K 513K n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a -2.07M -2.07M -2.07M -2.07M n/a n/a n/a n/a 467K 467K 467K
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a -583K -583K -583K n/a 583K 583K 583K n/a n/a n/a n/a
Other Investing Acitivies
2.21M 5.81M 5.85M 5.1M 2.84M 4.28M 3.55M 7.14M 7.79M 4.38M 6.44M 3.48M 2.8M 2.88M 2.44M 13.03M 12.85M 12.58M
Investing Cash Flow
-4.92M -3.96M -6.38M -5.27M -8.19M -6.3M -6.68M -3.18M -2.32M -6.32M -3.86M -8.61M -9.2M -8.72M -10.22M 1.92M 2.69M 1.73M
Debt Repayment
-24.08M -37M -38M -40.24M -36.27M -21.27M -10.27M -4.03M -3M -8M -15M -5M -22M -19M -71M -76M -78M -94M
Common Stock Repurchased
-10.04M -7.28M -5.31M -2.19M -2.21M -2.25M -2.2M -2.01M -1.94M -1.98M -3.9M -6.66M -9.39M -10.01M -8.26M -5.11M -2.39M -1.73M
Dividend Paid
-1.91M -1.87M -1.87M -1.85M -1.85M -1.86M -1.86M -1.9M -1.84M -1.83M -1.82M -1.79M -1.85M -1.85M -1.83M -1.82M -1.8M -1.78M
Other Financial Acitivies
154.06K -201.75K -778.75K 384.36K -474.33K -512.83K -1.41M -3.09M -3.86M -3.78M -2.31M -1.79M -26K -70K -1.37M -1.6M -3.1M -3.07M
Financial Cash Flow
-35.88M -46.36M -45.96M -45.06M -42.27M -28.59M -18.44M -12.54M -12.22M -15.93M -23.38M -15.61M -33.27M -30.93M -22.46M -24.53M -25.29M -40.58M
Net Cash Flow
13.49M 7.19M 4.04M 4.86M -8.51M -1.37M -308K 2.88M 10.06M -5.75M -2.27M -5.32M -17.47M -5.77M 3.9M 3.9M 12.66M 13.92M
Free Cash Flow
43.61M 43.9M 43.29M 43.69M 29.63M 21.99M 14.14M 8.7M 15.54M 6.37M 14.74M 5.95M 11.63M 20.82M 23.04M 14.42M 24.12M 41.45M